INTENSITY THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $8.00K.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $0.00.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $7.00M.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $56.00K, a 1.82% increase from fiscal 2024.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $55.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $56.00K 10-K · filed 2026-03-27 | |
| 2024-12-31 | $55.00K 10-K · filed 2026-03-27 | |
| 2024-03-31 | $8.00K 10-Q · filed 2025-11-06 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | |
| 2023-06-30 | $7.00M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |